Icon

VITEKTA (nda203093)- (85MG,150MG)

ELVITEGRAVIR GILEAD SCIENCES INC
85MG,150MG
No No
2027-Apr-26 2017-Aug-27
None 2017-Sep-24
None No
VITEKTA is a human immunodeficiency virus type 1 (HIV-1) integrase strand transfer inhibitor used in combination with an HIV protease inhibitor coadministered with ritonavir and with other antiretroviral drug(s) indicated for the treatment of HIV-1 infection in antiretroviral treatment-experienced adults.
0 0 0
Total Other Developers None
Drugs with Suitability No
85MG ** ** - - -
150MG ** ** - - -
NDA Sales Available Total Generic Sales Available
No 0
ANDA No Generic Co Manufacturer Name Operations Manufacturer Address Country

GenUs Advanced Search




Expired
to
Expired
to


Please contact contact@researchdelta.com to get more details.